ART-160

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameART-160
Drug Alias Nameanti-PAMP antibodies (Arana)anti-proadrenomedullin N-terminal 20 peptide antibodies (Arana)ART-160
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAdrenomedullin modulators
TargetsAdrenomedullin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArana Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArana Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A